HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, Ce A, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS.
Desai K, et al. Among authors: ce a.
Tumour Biol. 2017 Mar;39(3):1010428317695028. doi: 10.1177/1010428317695028.
Tumour Biol. 2017.
PMID: 28349782
Free article.